Background
==========

Colorectal cancer (CRC) is the second most frequent cancer and the second leading cause of cancer death in Europe \[[@B1]\]. CRC survival rates across the continent have increased mainly due to improvements in diagnosis and treatment with a mean survival rate of 56.2% at five years according to European cancer registries \[[@B2]\]. Survival depends mostly on stage at the time of diagnosis \[[@B3]\]. However, late diagnosis or treatment have also been considered as predictors of stage and survival, although these results are controversial \[[@B4]-[@B6]\].

Factors associated with the time interval between symptom onset and diagnosis or treatment are not sufficiently understood, regardless of whether they are related to the patient, the GP or the hospital setting. Theoretical frameworks used in cancer diagnosis research conceptualized time intervals occurring between phases of decision-making. \[[@B7],[@B8]\]. These early models, recently refined by Walters et al. \[[@B9]\], included four intervals: 'appraisal', 'help-seeking' 'diagnostic' and 'pre-treatment', in an attempt to represent the processes occurring during each. In fact, the CRC diagnosis process is complex and difficulties may arise at any point along the clinical pathway. Firstly, the patient and his/her social context response, when faced with symptom onset, could determine time elapsed before seeking help \[[@B10]\]. In this sense, the severity value given to a symptom, and the attitudes when dealing with a possible cancer, can lead to either early help-seeking or waiting for the symptoms to clear up \[[@B11]\]. Moreover, in most cases, the tumor appears with very common and non-specific symptoms, and general practitioners (GPs) and secondary care specialists are required to differentiate between patients whose symptoms may be due to cancer and others whose symptoms are attributable to benign, transitory illness \[[@B12]-[@B14]\].

While there are recent rigorous studies on time duration to cancer diagnosis or treatment, much of the relevant literature is old and presents methodological issues that need to be taken into account such as different ways of measuring symptom duration and accuracy in recording symptom presentation \[[@B4],[@B5]\].

Care continuity problems in CRC diagnosis have been highlighted in several countries, and health authorities advocate reduction in the time interval between suspicion of CRC and diagnosis or treatment. Various initiatives have been set up to identify those patients with symptoms related to CRC that suggest a need for prompt investigation \[[@B15],[@B16]\].

In this study we try to address several issues. Firstly, to identify the delays that may occur at various stages along the clinical pathway in accordance with theoretical models, the factors associated with symptom duration and where there is greatest potential for improvement. Secondly, to overcome some of the problems identified in our reviews with a wider spectrum of patients and provide more accurate definitions of time intervals all over the diagnosis pathway and symptom presentation.

The aims of the study are: 1) to establish the distinct time-intervals to diagnosis and treatment; 2) to identify factors associated with late diagnosis and treatment.

Methods
=======

Setting and study population
----------------------------

This paper reports findings from a larger study whose methods have been published elsewhere \[[@B17]\]. This is a cross-sectional study carried out in 5 Spanish regions. Briefly, subjects were consecutive incident cases of CRC (IDC9 153 and 154), verified histologically, between September 2006 and September 2008 and registered with a GP. Prevalent or recurrent cases were excluded as well as patients with multiple tumors and those diagnosed in private hospitals. For the present analysis, non-symptomatic patients were also excluded (screening detected cases, incidental findings).

Patients were identified at diagnosis through results of histological findings from endoscopy or surgery and contacted during the inpatient stage or oncology visit by their surgeon or oncologist who invited them to participate.

Measurements
------------

Data were obtained from patient interviews together with primary care and hospital clinical records review. Each of the patients was interviewed after diagnosis using a structured questionnaire during the inpatient stage, oncology visit or, if this were not possible, at home by a trained nurse or GP. Informed consent for study participation and access to medical records was obtained during the interview. In cases where the patient was deceased or could not be interviewed for other reasons, permission to review patient clinical records was obtained from a close family member. Details about measurements can be found in Additional file [1](#S1){ref-type="supplementary-material"}.

Interview measurements: Each patient was asked how long he/she had been feeling unwell and given a checklist to identify the type of symptom/s noted \[[@B18]\]. Symptoms spontaneously mentioned by the patient were considered the initial symptom/s for that patient and the date was recorded. Additional presenting symptoms were recorded. Other variables were social class \[[@B19]\] and demographic characteristics, perception of symptom seriousness, disclosure of symptoms, help-seeking action, doctor-patient relationship, and familial history of cancer. Primary care measurements were: date of first symptom and other symptoms, date of first contact with GP due to CRC symptoms, examinations and visits before diagnosis and their results, and date and information included in the referral. Hospital record measurements were: tumor data, date of first symptom and other symptoms, intestinal obstruction, date of first contact due to CRC symptoms, date of diagnosis, service attending the patient, examinations and visits before diagnosis and their results, and date and type of treatment.

Symptom duration was divided into several intervals
---------------------------------------------------

Symptom Diagnosis Interval (SDI): from onset of first CRC symptoms to date of diagnosis.

Symptom Treatment Interval (STI): from onset of first CRC symptoms until start of treatment.

Patient Interval (PI): from onset of first CRC symptoms to date of first consultation with a physician (GP or hospital specialist).

Health Services Interval (HSI): Interval from 1st contact with a physician to diagnosis.

Treatment interval (TI): Interval from date of diagnosis to date of treatment.

In order to calculate time intervals, it was necessary to establish several definitions:

Date of onset of the first symptom/s was the one referred to by the patient. In the case of no interview, the date of 1st symptom recorded in the primary health care record or in the hospital record was used.

Date of diagnosis, i.e., date of first positive histology report. Date of treatment, i.e., date of surgery, date of preoperative or postoperative radiotherapy or chemotherapy or date of palliative treatment. For those patients who did not receive any treatment, the date of the visit closest to the decision not to treat the patient was recorded.

Statistical analysis
--------------------

The graphical analysis of interval times showed skewed distributions confirmed with the Kolmogorov-Smirnov test. Diagnosis or treatment intervals are presented as median and 25--75 percentiles. To assess the relationship between the different types of symptom interval duration and the observed variables, we used the Mann--Whitney U test for dichotomous variables and Kruskal-Wallis test for those variables with more than two categories. In order to avoid symptoms that could not be related to CRC, no more than a 24-month interval between symptom and diagnosis was accepted. Nineteen patients (0.3%) had a SDI of 24 months and twenty-one (0.7%) in the case of STI. All statistical analyses were performed using SPSS v.15.0.

This Study was approved by the Primary Health Care Committee of each health district and by the Ethical and Clinical Research Committee of each participating region.

Results
=======

A total of 950 incident colorectal cancer patients were recruited. For the present study, 155 asymptomatic patients were excluded; 94 (9.9%) screen detected and 61 (6.4%) incidental findings. Finally, 795 symptomatic cases were included; 481 (60.5%) were colon cases and 314 (39.5%) rectum. Hospital record information was available for all patients and primary care records for 780 patients (98.1%). In 66 (8.3%) patients the interview was not completed. The interview was completed during inpatient stay in 310 patients (44.7%), prior to surgery in 48 (6.9%), during outpatients visits in 267 (38.5%) and 69 (9.9%) at home.

Various time intervals are shown in Table [1](#T1){ref-type="table"}. The median SDI and STI for CRC were 128 and 155 days respectively. Three months following symptom onset, four in ten patients are diagnosed and nearly three treated. No statistically significant differences were observed in SDI between colon and rectum, 125 (59--258) vs. 121 (53--256) respectively (p=0.51), or in STI 150 (80--280.5) vs. 153 (79--283), (p=0.08). Most of the treatment interval stemmed from health services time interval to diagnosis and less from the patient or interval from diagnosis to treatment.

###### 

Distribution of delay intervals (in days)

                    **Symptom diagnosis interval**   **Symptom treatment interval**   **Symptom-patient first contact with a doctor interval**   **Health services interval**   **Diagnosis to treatment interval**
  ---------------- -------------------------------- -------------------------------- ---------------------------------------------------------- ------------------------------ -------------------------------------
                           Median (P25-P75)                 Median (P25-P75)                              Median (P25-P75)                             Median (P25-P75)                  Median (P25-P75)
    Colon & rectum         128 (57.5-257.5)                 155 (84.0-283.5)                                 19 (3--83)                                  66 (25--159)                       22 (8--37)
             Colon         125 (59.0-258.0)                 150 (80.0-280.5)                                 18 (3--74)                                 64 (23--164.5)                      18 (4--33)
            Rectum         121 (53.0-256.0)                 153 (79.0-283.0)                                20 (3--83.2)                                 62 (22--156)                       22 (8--38)
                                 N(%)                             N(%)                                          N(%)                                         N(%)                              N(%)
    Colon & Rectum                                                                                                                                                                                
        \< 1 month            110 (14.1)                        59 (7.9)                                     483 (61.7)                                   245 (30.8)                        501 (65.8)
        1-3 months            190 (24.3)                       152 (20.4)                                    139 (17.8)                                   235 (29.6)                        234 (30.7)
        3-6 months            207 (26.5)                       215 (28.9)                                    80 (10.2)                                    149 (18.7)                         16 (2.1)
    6 month-1 year            165 (21.1)                       184 (24.7)                                     35 (4.5)                                    109 (13.7)                          9 (1.2)
         \> 1 year            109 (14.0)                       134 (18.0)                                     46 (5.9)                                     57 (7.2)                           1 (0.1)

Women present higher diagnostic time intervals than men. No significant differences in symptom duration intervals were found for age, level of education, social class or marital status. Finally, those patients with family history of cancer had longer diagnosis and treatment time intervals (Table [2](#T2){ref-type="table"}).

###### 

Socio-demographic characteristics

                                                                **N %**     **Symptom diagnosis interval median (P25-P75) (days)**   **Symptom treatment interval median (P25-P75) (days)**
  ----------------------------------------------------------- ------------ -------------------------------------------------------- --------------------------------------------------------
                                                       Gender                                                                                                   
                                                          Men  489 (62.7)                      113 (51.0-246.0)                                         144 (84.0-273.7)
                                                        Women  291 (37.3)                      153 (73.0-274.0)                                         175 (93.0-289.0)
                                                            P                                       \<0.01                                                    0.07
                                                    Age group                                                                                                   
                                                         \<50   45 (5.7)                     171.0 (127.2-246.2)                                      149.0 (104.0-214.0)
                                                        50-64  188 (24.2)                     163.0 (87.5-295.5)                                       133.0 (60.5-254.5)
                                                        65-74  223 (28.1)                     137.0 (83.0-255.2)                                       112.5 (49.0-224.7)
                                                        \>=75  321 (41.3)                     159.5 (84.0-326.2)                                       132.0 (62.5-289.5)
                                                            P                                        0.34                                                     0.20
                                               Marital Status                                                                                                   
                                                       Single   61 (8.4)                       130 (48.0-342.0)                                        157.5(75.5-359.0)
                                                      Married  517 (71.1)                      120 (57.0-245.5)                                        153.0 (89.0-272.0)
                                     Widow/Separated/Divorced  149 (20.5)                      154 (77.5-306.5)                                        178.0 (96.0-336.7)
                                                            P                                        0.09                                                     0.40
                                           Level of Education                                                                                                   
                                Illiterate-incomplete primary  106 (14.6)                     127.0 (39.0-265.5)                                       151.0 (73.0-282.0)
                                            Primary education  402 (55.3)                     132.0 (66.0-270.0)                                       163.0 (93.2-295.7)
                                          Secondary education  101 (13.9)                     130.0 (70.5-214.5)                                       160.0 (88.5-264.5)
                                                  High School   72 (9.9)                      122.0 (47.0-311.0)                                       155.0 (79.0-343.0)
                                         University education   46 (6.3)                      103.5 (34.5-232.2)                                       127.0 (55.5-260.0)
                                                            P                                        0.78                                                     0.78
                                                 Social Class                                                                                                   
                                                 Class I & II   58 (9.0)                      145.5 (67.7-267.5)                                       146.5 (80.5-313.5)
                                                    Class III  154 (23.8)                     133.0 (63.0-320.5)                                       163.0 (89.5-354.0)
                                                    Class IVa  208 (32.2)                     120.0 (58.5-223.5)                                       154.5 (93.5-255.0)
                                                    Class IVb  102 (15.8)                     131.0 (66.5-244.5)                                       170.5 (92.2-296.2)
                                                      Class V  124 (19.2)                     128.0 (48.5-229.0)                                       155.0 (77.5-257.0)
                                                                                                     0.86                                                     0.73
    History of cancer in family members and/or acquaintances'                                                                                                   
                                                          Yes  329 (45.3)                     138.0 (70.0-276.0)                                       169.5 (96.2-313.7)
                                                           No  398 (54.7)                     124.5 (56.0-227.0)                                      147.0 (78.5-259.5.2)
                                                            P                                        0.07                                                     0.01

Concerning initial symptoms (Table [3](#T3){ref-type="table"}), the presence of abdominal pain, vomiting and intestinal obstruction are associated with shorter time between symptom onset and diagnosis or treatment. There were no differences between SDI and STI with regard to other symptoms or the number of symptoms at presentation. Moreover, we observed a clear gradient in the duration of SDI depending on perceived symptom severity with shorter SDI and STI for those perceived as very serious. Therefore, the duration of intervals is related to patient attitude toward the symptom, that is, the interval duration diminishes when patients disclose the symptom to those close to them; when they do not wait for symptom clear up, or when they visit emergency services (either primary care or hospital). We found an association between trust in the GP and time to diagnosis or treatment.

###### 

Relationship with presenting symptom, help-seeking behaviour and trust in their GP

                                      **N (%)**    **Symptom diagnostic interval**   **Symptom treatment interval**
  ---------------------------------- ------------ --------------------------------- --------------------------------
                      Abdominal pain                                                                
                                 Yes  195 (27.3)         117.0 (41.0-220.0)                137.0 (58.0-252.0)
                                  No  520 (72.7)         133.0 (66.0-280.0)                171.0 (96.7-314.0)
                                   P                            0.01                            \<0.001
                          Other pain                                                                
                                 Yes   50 (7.0)          122.5 (66.7-359.0)                159.5 (98.7-394.5)
                                  No  665 (93.0)         130.0 (59.0-259.0)                159.0 (87.0-288.0)
                                   P                            0.70                              0.52
                     Rectal Bleeding                                                                
                                 Yes  285 (39.9)         118.0 (51.5-260.0)                169.0 (89.0-298.0)
                                  No  430 (60.1)         136.0 (63.0-263.0)                154.0 (85.5-282.5)
                                   P                            0.38                              0.43
             Changes in bowel habits                                                                
                                 Yes  273 (38.2)         128.0 (57.0-229.0)                152.0 (86.7-275.0)
                                  No  442 (61.8)         130.5 (61.7-275.2)                162.0 (89.0-317.0)
                                   P                            0.28                              0.28
                            Vomiting                                                                
                                 Yes   24 (3.4)           49.0 (10.2-134.7)                71.0 (13.0-154.0)
                                  No  691 (96.6)         131.0 (63.0-264.5)                161.5 (91.0-291.2)
                                   P                           \<0.001                          \<0.001
                            Tenesmus                                                                
                                 Yes   38 (5.3)          146.0 (51.0-272.0)                181.0 (93.5-325.5)
                                  No  677 (94.7)         130.0 (60.0-262.2)                155.5 (87.0-286.2)
                                   P                            0.67                              0.40
                    Loss of appetite                                                                
                                 Yes   49 (6.9)          133.0 (45.0-192.0)                135.0 (59.2-214.7)
                                  No  666 (93.1)         130.0 (61.0-268.0)                159.0 (89.0-296.0)
                                   P                            0.24                              0.10
                      Loss of weight                                                                
                                 Yes   57 (8.0)          121.0 (58.5-200.0)                154.0 (92.0-233.0)
                                  No  658 (92.0)         130.0 (60.0-271.0)                159.0 (87.5-299.5)
                                   P                            0.31                              0.36
                             Fatigue                                                                
                                 Yes  97 (13.6)          145.0 (72.0-266.0)                172.0 (93.0-295.0)
                                  No  618 (86.4)         128.0 (56.0-261.0)                155.0 (86.7-287.5)
                                   P                            0.29                              0.49
                             Anaemia                                                                
                                 Yes   51 (7.1)          133.0 (43.0-365.0)                158.0 (66.0-515.0)
                                  No  664 (92.9)         130.0 (61.0-256.2)                159.0 (90.0-282.0)
                                   P                            0.66                              0.44
                         Obstruction                                                                
                                 Yes  106 (13.6)          88.0 (26.0-165.5)                86.0 (20.5-159.0)
                                  No  675 (86.4)         131.0 (64.0-269.0)                169.0 (94.0-304.5)
                                   P                           \<0.001                          \<0.001
              Nº of initial symptoms                                                                
                                   1  417 (58.3)         131.0 (62.5-271.5)                160.5 (91.7-289.7)
                                   2  160 (22.4)         124.0 (59.5-300.2)                158.5 (84.0-330.2)
                                   3  72 (10.1)          143.5 (70.2-246.5)               161.0 (100.0-264.0)
                                \> 3   66 (9.2)           89.0 (40.5-182.0)                117.5 (60.7-223.0)
                                   P                            0.12                              0.21
           Perception of seriousness                                                                
                         Not serious  467 (65.6)         142.0 (67.5-285.5)                171.0 (94.0-316.5)
                       Quite serious  162 (22.8)         117.0 (61.7-263.2)                153.0 (91.0-296.5)
                        Very serious   48 (6.7)           83.0 (34.2-129.2)                119.0 (65.0-180.0)
                               Other   35 (4.9)          110.0 (43.0-229.0)                118.0 (68.0-247.0)
                                   P                           \<0.001                           \<0.01
                  Symptom Disclosure                                                                
                                 Yes  87 (12.1)          126.0 (56.0-255.0)                155.0 (84.0-282.5)
                                  No  634 (87.9)         152.5 (86.7-340.5)               173.0 (108.5-354.0)
                                   P                            0.04                              0.06
              Help Seeking behaviour                                                                
                    Visited a doctor  494 (68.8)         123.5 (50.7-230.2)                153.0 (78.5-264.0)
                   Wait for clear up  184 (25.6)         167.5 (88.0-344.7)               187.5 (119.0-273.0)
                               Other   40 (5.6)           83.0 (33.7-200.0)                95.0 (45.2-232.0)
                                   P                           \<0.001                          \<0.001
       Health services first contact                                                                
                          With my GP  530 (72.7)         147.5 (77.0-278.5)                174.0 (99.0-307.7)
         Family Practice emergencies   37 (5.1)           85.5 (30.7-151.2)                114.0 (39.5-179.2)
                Hospital emergencies  101 (13.9)          71.0 (22.0-169.7)                84.0 (36.0-204.0)
               To my hospital doctor   27 (3.7)          146.0 (96.0-293.0)               190.5 (130.2-344.7)
                 To Private hospital   14 (1.9)           95.0 (67.7-344.7)                181.0 (113.0-32.0)
                               Other   20 (2.7)           66.0 (29.5-153.5)                111.0 (44.0-197.0)
                                   P                           \<0.001                          \<0.001
    Would you recommend your doctor?                                                                
               Yes without any doubt  412 (63.2)         129.0 (59.5-266.5)                156.0 (87.0-289.0)
                        Probably yes  171 (26.2)         128.0 (56.0-260.0)                159.0 (84.0-307.0)
                        Probably not   35 (5.4)          130.0 (88.0-213.0)               155.0 (105.0-268.5)
                      Absolutely not   34 (5.2)          224.0 (133.7-361.5)              228.0 (152.5-362.5)
                                   P                            0.02                              0.11

With regard to GP performance (Table [4](#T4){ref-type="table"}), some non-indicated investigations, such as abdominal transit and gastroscopy were prescribed very rarely: in only 6 and 16 patients, respectively. GPs requested 109 colonoscopies, 4 rectoscopies and 3 rectosigmoidoscopies. When general practitioners ask for diagnostic tests of blood, iron, or blood in the stools, the time to diagnosis or treatment increases. No relationship has been detected between these time intervals and lack of abdominal or rectal examination and other image investigations. Shorter SDI and SDT were observed when the general practitioner referral to hospital was urgent or when the GP mentioned suspected diagnosis in the referral. Greater duration to diagnosis was observed in those with an increasing number of visits to the GP for symptoms related to CRC and shorter duration for those frequently attended by their family or nursing practitioner in the previous year.

###### 

Relationship of GP performance with delay

                                               **N (%)**    **Symptom diagnosis interval**   **Symptom treatment interval**
  ------------------------------------------- ------------ -------------------------------- --------------------------------
                        Abdominal exploration                                                               
                                          Yes  244 (30.7)         125.0 (67.0-223.0)               155.5 (93.2-259.2)
                                           No  550 (69.3)         149.0 (70.0-280.0)               181.0 (93.7-315.2)
                                            P                            0.15                             0.09
                           Rectal examination                                                               
                                          Yes  180 (32.8)         129.0 (72.0-250.0)               166.0 (98.2-279.0)
                                           No  369 (67.2)         142.0 (69.5-261.0)               168.0 (91.7-291.0)
                                            P                            0.69                             0.89
                          Faecal occult blood                                                               
                                          Yes  112 (20.3)         176.0 (89.5-292.0)              202.5 (118.7-324.5)
                                           No  440 (79.7)         128.0 (62.0-248.0)               159.5 (89.7-278.2)
                                            P                            0.01                             0.01
                                   Blood test                                                               
                                          Yes  314 (56.9)         165.0 (88.7-300.7)              188.0 (114.0-323.0)
                                           No  238 (43.1)         103.5 (44.7-223.2)               132.0 (77.5-251.5)
                                            P                          \<0.001                          \<0.001
                Iron deficiency investigation                                                               
                                          Yes  117 (21.4)        176.0 (100.0-328.0)              213.0 (116.5-364.0)
                                           No  431 (78.6)         127.0 (63.0-251.5)               160.0 (89.5-272.5)
                                            P                           \<0.01                           \<0.01
                                 Abdominal XR                                                               
                                          Yes   22 (4.0)          180.5 (76.0-257.0)               187.0 (69.0-269.0)
                                           No  528 (96.0)         132.5 (68.5-258.0)               166.0 (94.0-290.0)
                                            P                            0.36                             0.90
                         Abdominal Echography                                                               
                                          Yes   52 (9.5)          145.5 (73.0-256.0)               165.5 (86.2-261.7)
                                           No  498 (90.5)         136.0 (69.0-258.0)               167.5 (94.0-289.5)
                                            P                            0.74                             0.74
                                 Barium enema                                                               
                                          Yes   38 (6.9)          132.0 (60.0-272.2)               163.0 (96.0-306.0)
                                           No  512 (64.4)         137.5 (70.0-257.7)               167.0 (93.0-287.0)
                                            P                            0.71                             0.97
                                  Colonoscopy                                                               
                                          Yes  109 (19.8)         165.0 (82.5-291.0)              195.0 (132.5-322.0)
                                           No  441 (80.2)         129.5 (64.0-251.0)               157.0 (89.5-282.0)
                                            P                            0.02                            \<0.01
                   First referral to hospital                                                               
                             Gastroenterology  218 (58.6)         149.5 (77.2-291.2)              185.0 (114.0-317.0)
                                      Surgery   36 (9.7)          153.5 (58.0-291.0)              181.0 (115.2-299.0)
                            Internal Medicine   13 (3.5)          150.0 (81.0-247.5)              162.5 (106.0-228.2)
                            Emergency service  89 (23.9)          125.0 (50.0-238.7)               158.0 (82.7-249.0)
                                       Others   16 (4.3)         220.5 (117.5-351.7)              232.0 (138.0-327.0)
                                            P                            0.27                             0.36
                             Type of referral                                                               
                                     Ordinary  126 (37.5)         181.0 (84.0-303.0)              195.0 (117.2-304.2)
                                 Preferential  99 ( 29.5)         163.0 (85.0-294.0)              193.0 (117.2-317.7)
                                       Urgent  111 (33.0)         111.5 (56.5-208.2)               152.0 (90.0-237.0)
                                            P                           \<0.01                           \<0.01
                          Diagnosis suspicion                                                               
                                          Yes  184 (54.6)         129.0 (62.0-265.0)               166.0 (92.0-297.0)
                                           No  153 (45.4)         172.5 (86.7-292.0)              195.0 (119.0-317.0)
                                            P                            0.06                             0.03
             CRC suspicion in referral letter                                                               
                                          Yes  71 (22.4)          112.0 (63.7-215.7)              153.0 (106.0-247.0)
                                           No  246 (77.6)         166.0 (78.0-304.0)              191.0 (109.0-318.0)
                                            P                            0.04                             0.03
         Number of visits due to CRC symptoms                                                               
                                            0  142 (25.9)         08.0 (48.2-205.75)               143.0 (83.0-241.7)
                                          1-2  211 (38.5)         124.5 (59.7-223.0)               153.0 (87.7-256.2)
                                          3-5  138 (25.2)         163.0 (81.0-296.2)              183.0 (104.0-308.5)
                                         \>=6  57 (10.4)          264.0 (27.7-393.7)              279.5 (165.0-405.7)
                                            P                          \<0.001                          \<0.001
    Visits in last 12 months before diagnosis                                                               
                                            0   7 (1.3)           212.0 (20.0-662.0)               244.0 (57.0-185.0)
                                          1-5  148 (27.0)         126.5 (70.5-229.5)               169.0 (94.0-259.5)
                                         6-12  194 (35.3)         120.0 (60.0-222.0)               153.0 (84.0-255.0)
                                        13-24  139 (25.3)         160.0 (80.0-214.0)             182.5 (108.2.0-358.5)
                                        \>=25  61 (11.1)          154.5 (75.2-244.0)               171.0 (92.0-296.0)
                                            P                            0.06                             0.05

CRC: Colorectal Cancer.

Regarding secondary care of CRC cases (Table [5](#T5){ref-type="table"}), we observed that the first contact is made mainly through the Emergency or Gastroenterology services. Sixty-three per cent of patients were referred by their GP and a quarter contacted hospitals by themselves. Shorter intervals are observed when the patient contacts the emergency service on his or her own initiative. Additionally, patients with abdominal or rectal examination, blood test, XT or CT, are diagnosed or treated earlier; in contrast with patients with MRI.

###### 

Performance of hospital doctors and relationship with delay

                                                        **N (%)**    **Symptom diagnosis**   **Symptom treatment interval**
  ---------------------------------------------------- ------------ ----------------------- --------------------------------
                         Service of first consultation                                                      
                                      Gastroenterology  312 (39.5)    168.0 (90.0-317.5)           199 (124.0-352.0)
                                       General Surgery   52 (6.6)     159.0 (83.5-349.0)           223 (128.0-382.5)
                                     Internal Medicine   36 (4.6)     146.5 (70.7-315.5)           145.5 (90.0-334.0)
                                     Emergency service  363 (46.6)     88.0 (33.5-186.5)           108.0 (52.0-207.5)
                                                 Other   26 (3.3)     149.0 (84.0-281.0)          176.0 (103.0-294.5)
                                                     P                      \<0.001                     \<0.001
                                 Contact with hospital                                                      
                                  Patient own referral  178 (24.8)     84.0 (27.5-163.5)           111.0 (40.0-210.5)
                            GP or out of hours service  452 (63.0)    140.0 (70.0-271.0)           171.0 (97.0-306.0)
                            Referral other specialists   54 (7.5)     126.0 (75.7-352.5)          144.5 (101.0-364.2)
                                                 Other   37 (4.7)     109.0 (66.5-240.7)           127.5 (85.2-264.5)
                                                     P                      \<0.001                     \<0.001
                                       Requested tests                                                      
                                 Abdominal examination                                                      
                                                    Si  583 (73.6)    111.0 (49.0-238.0)           136.0 (71.0-268.0)
                                                    No  209 (26.4)    144.0 (78.2-293.7)          189.0 (111.2-329.5)
                                                     P                      \<0.01                      \<0.001
                                    Rectal Examination                                                      
                                                    Si  423 (53.3)    118.0 (49,0-224,0)           151.0 (75.0-274.0)
                                                    No  370 (46.7)    132.0 (68.5-284.5)           162.0 (92.0-315.0)
                                                     P                       0.05                         0.09
                                     Faecal Blood Test                                                      
                                                    Si   41 (5.2)     150.0 (72.5-269.5)          193.0 (101.0-362.0)
                                                    No  752 (94.8)    127.0 (55.0-253.0)           154.0 (84.0-281.0)
                                                                             0.68                         0.28
                                            Blood Test                                                      
                                                    Si  573 (72.5)     116.0(49.0-238.0)           139.0 (72.0-262.0)
                                                    No  217 (27.5)     144.5(83.0-290.5)          189.0 (119.5-335.2)
                                                     P                      \<0.001                     \<0.001
                                    Iron Investigation                                                      
                                                    Si  227 (28.7)    137.5 (61.0-286.0)           166.0 (90.0-314.0)
                                                    No  563 (71.3)    125.0 (55.5-245.0)           154.0 (83.02-75.5)
                                                     P                       0.23                         0.36
                                          Abdominal XR                                                      
                                                    Si  274 (34.6)     98.0 (33.0-195.0)           110.0 (48.5-211.5)
                                                    No  519 (65.4)    142.0 (72.0-293.0)          177.0 (108.5-318.5)
                                                     P                      \<0.001                     \<0.001
                                  Abdominal Echography                                                      
                                                    Si  141 (17.8)    113.5 (59.0-241.0)           134.5 (89.2-259.0)
                                                    No  652 (82.2)    130.0 (53.0-256.0)           160.5 (83.7-287.5)
                                                     P                       0.51                         0.20
                                          Barium Enema                                                      
                                                   Yes   61 (7.7)     145.0 (76.0-276.0)           179.0 (77.0-343.0)
                                                    No  731 (92.3)    124.0 (56.5-251.0)          154.0 (84.0-281.25)
                                                     P                       0.63                         0.63
                                        Barium transit                                                      
                                                   Yes   11 (1.4)     193.0 (84.5-247.0)           233.0 (47.0-291.0)
                                                    No  782 (98.6)    125.5 (57.0-253.0)           154.0 (84.0-282.0)
                                                     P                       0.54                         0.56
                                           Gastroscopy                                                      
                                                   Yes  92 (11.6)     117.0 (72.0-280.0)           167.0 (92.0-321.0)
                                                    No  699 (88.4)    127.0 (53.0-250.5)           154.0 (83.5-275.5)
                                                     P                       0.41                         0.34
                                            Rectoscopy                                                      
                                                   Yes   35 (4.4)     182.0 (66.0-324.0)          204.0 (103.7-388.0)
                                                    No  755 (95.6)    125.5 (56.0-251.0)           154.0 (83.5-280.0)
                                                     P                       0.19                         0.06
                                    Rectosigmoidoscopy                                                      
                                                   Yes   18 (2.3)      83.0 (43.0-180.0)           116.5 (77.0-221.2)
                                                    No  772 (97.7)    128.0 (59.0-255.0)           155.0 (84.0-287.0)
                                                     P                       0.30                         0.46
                                     CT Abdominal Scan                                                      
                                                   Yes  345 (43.6)    112.0 (45.5-221.5)           128.0 (69.2-244.7)
                                                    No  447 (56.4)    142.0 (64.0-280.0)           180.0 (97.5-316.5)
                                                     P                       0.01                       \<0.001
                                         Abdominal MRI                                                      
                                                   Yes   40 (5.1)     194.0 (84.0-403.0)          227.0 (112.5-451.0)
                                                    No  751 (94.9)    124.5 (56.0-251.0)           153.5 (83.0-276.7)
                                                     P                       0.02                         0.01
    Diagnosis orientation after first Hospital contact                                                      
                                               Correct  386 (50.5)    113.5 (55.7-228.5)           146.5 (83.5-263.5)
                                           Appropriate  334 (43.7)    140.0 (58.0-257.5)           158.0 (78.5-297.5)
                                         Inappropriate   44 (5.8)     137.0 (82.0-256.2)          172.0 (111.5-298.2)
                                                     P                       0.39                         0.50

*XR* Radiography, *CT* computed tomography, *MRI* Magnetic Resonance Image.

Discussion
==========

This study has used a comprehensive approach in assessing the factors that underlie the social and clinical pathway to cancer diagnosis duration in CRC. Findings show, as in the review of Mitchell et al. \[[@B11]\], the complex relationship between symptom presentation and patient behaviour regarding perception and response to the symptoms. Moreover, our results add more information on the effect in time elapsed from symptom to diagnosis or treatment of factors such as gender, attitude towards symptoms, appropriate GP referral and hospital doctor performance.

First of all, after experiencing the first CRC symptoms, half of the patients have to wait at least 4 months until diagnosis. This finding is similar to that described by others \[[@B20]-[@B24]\]. Most notable is the fact that one third has to wait more than six months to be diagnosed. In accordance with other findings \[[@B20],[@B25]\], no differences in distinct symptom duration intervals by cancer site were detected, although some studies reported longer time for rectum \[[@B26],[@B27]\].

Women in our study are more likely to experience longer time to diagnosis than men. These results probably are related to gender differences in coping with symptoms and help-seeking behaviour \[[@B10],[@B28]-[@B30]\]. Women push men to see a doctor when they have CRC symptoms while the women themselves wait for symptoms to clear up \[[@B8]\] because of fear of having cancer \[[@B31]\]. In fact, waiting for symptom clear-up was associated in our study with not being diagnosed or treated promptly.

There are no conclusive results on socioeconomic status and time elapsed to diagnosis and treatment. Some studies show longer symptom duration in those patients with lower social status \[[@B22],[@B28],[@B32],[@B33]\] while our data, in accordance with others \[[@B34],[@B35]\], could not confirm these differences. Longer lag time is also seen in those patients with history of cancer in family members, friends or colleagues. These factors have not been researched in depth with regard to CRC and delay \[[@B11]\]. While Ratcliffe et al. describe no differences in time intervals in those with or without family history of cancer \[[@B36]\], other authors have suggested that prior experience of the disease through relatives or friends could result in putting medical consultation off \[[@B10],[@B37]\].

Regarding symptom at presentation, we confirmed that abdominal pain \[[@B38]-[@B40]\] and vomiting \[[@B32],[@B39]\] lead to shorter interval duration. At the same time, as described by other authors \[[@B28],[@B40]\], our results show that beliefs that the symptom is serious and symptom disclosure to friends and family are strongly associated with shorter lag times. Again, this could be related to gender, as women with CRC symptoms generally say nothing to their families until they have already visited a doctor \[[@B10]\].

Current practice by general practitioners may contribute to lengthen time to diagnosis. For instance, we observed that when the GP requests some tests to diagnose anemia, the diagnosis process is extended \[[@B41]\]. Unfortunately, there is no simple solution to this. When dealing with a symptom such as anemia, with low predictive value, doctors must confirm non-malignancy before filling outpatient services with mild pathologies \[[@B13],[@B14]\]. Similarly, misinterpretation of a symptom may result in a greater number of visits to a doctor before referral to a specialist \[[@B32]-[@B34],[@B39]-[@B43]\], and this is a variable associated in our study with longer time to diagnosis or treatment.

Furthermore, erroneous orientation can be the result of poor examination and misdiagnosis. Our results show that the GP only carried out physical examination of one in three patients; in fact, prior studies have pointed out insufficient physical examination by the GP, and no improvement has been observed over time \[[@B40]-[@B42]\]. Lack of physical examination and poor investigations by outpatient or emergency doctors seem to have more consequences than family doctor performance \[[@B32]\]. This could be partly due to the fact that a misdiagnosis in a primary care visit is less important because continuity of care is highly assured. A misdiagnosis in outpatient care would be more relevant because a further appointment is considerably more difficult to make.

On the other hand, the capacity of the GP to form a suspicion of CRC in the referral has been shown to be a key factor as it predicts less time to diagnosis. This may be because when the GP has a clear suspicion, the referral is made more promptly and the response of hospital doctors to this type of referral is faster \[[@B44],[@B45]\].

Strengths and limitations
-------------------------

In contrast with previous studies limited to the assessment of partial time intervals to diagnosis or treatment (patient or system time intervals), we have been able to show that these factors also affect total time to diagnosis or treatment. Our findings show a similar relationship for time to diagnosis and time to treatment with the various factors studied. This fact demonstrates that the variables considered in this study have great influence on the time to diagnosis and, as a matter of fact, duration between diagnosis and treatment is relatively less relevant (\>65% of those diagnosed are treated within a month). The inclusion of a high number of hospitals and primary care centers could imply high heterogeneity in data acquisition, but at the same time represents a complete picture of patterns of care, preventing the selection bias that appears when only a single centre is included.

The major limitation of this study lies in the lack of a consistent methodology to precisely measure the date of symptom presentation. The date of onset of symptoms obtained from the patient interview has been questioned. According to some authors, studies fail to consider existing theories of symptom interpretation. The interpretation of bodily sensations as symptoms is embedded within a social and cultural context and respondents do not define time periods in the same way \[[@B46]\]. Therefore, this date may be quite precise for acute symptoms, such as rectal bleeding, but difficult to establish for more general symptoms such as fatigue \[[@B47]\]. However, other studies have shown good agreement when comparing information expressed by patients and doctors \[[@B18],[@B48]\]. Retrospective review of clinical records presents the same type of problem because it comes from patient information provided to doctors. Furthermore, some of the symptoms described to doctors may go unrecorded, as highlighted by some authors \[[@B49],[@B50]\]. Patient interviews conducted during pre or post first treatment could result in memory biases. The Aarhus statement will facilitate standardized and uniform definition of studies in this area \[[@B51]\]. Finally, a trusting relationship with the GP, recorded after diagnosis, could be spurious as, patient faith in their GP, could be related to lag time to diagnosis or treatment \[[@B52],[@B53]\].

Conclusions
===========

In conclusion, a substantial proportion of CRC patients experience long diagnosis and treatment intervals with potential impact on psychological wellbeing, quality of life or even survival. Time taken to diagnosis and treatment of colorectal cancer appears to be subject to many previously suspected factors, symptom presentation, patient response to symptom, and general practice and secondary care performance factors.

Implications for further research and policy development
--------------------------------------------------------

Research is needed to develop interventions for use by primary and secondary care doctors to reduce diagnostic and treatment time intervals. Gender differences encountered in our population also deserve to be investigated more thoroughly. Further research into first-symptom presentation and concordance between patients and primary and hospital clinical records would give further insights into methodological issues in cancer delay studies.

The results of this work reveal the existence of areas for improvement in health care delivered to patients. Particularly important is to introduce changes to the existing guidelines whereby physical examination and laboratory and image investigations are carried out on all those who present with lower gastrointestinal symptoms independently of age, gender or symptom duration. This would also favour thorough information being included in the referral letter. If time to diagnosis is to be reduced, there must be development of interventions and guidelines to ensure appropriate diagnosis and examination during both primary and hospital care.
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